Your browser doesn't support javascript.
loading
Novel risk model based on angiogenesis-related lncRNAs for prognosis prediction of hepatocellular carcinoma.
Xie, Shicheng; Zhong, Jinwei; Zhang, Zhongjing; Huang, Weiguo; Lin, Xiaoben; Pan, Yating; Kong, Xiuyan; Xia, Hongping; Yu, Zhijie; Ni, Haizhen; Xia, Jinglin.
Affiliation
  • Xie S; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Zhong J; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Zhang Z; Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, China.
  • Huang W; Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, China.
  • Lin X; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Pan Y; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Kong X; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Xia H; School of Medicine & Advanced Institute for Life and Health, Zhongda Hospital, Southeast University, Nanjing, 210009, China.
  • Yu Z; Wenzhou Key Laboratory of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. zhijie_yu@wzhospital.cn.
  • Ni H; Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, China. shanice0208@sina.com.
  • Xia J; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China. xiajinglin@fudan.edu.cn.
Cancer Cell Int ; 23(1): 159, 2023 Aug 07.
Article in En | MEDLINE | ID: mdl-37550755
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancer Cell Int Year: 2023 Document type: Article Affiliation country: China Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancer Cell Int Year: 2023 Document type: Article Affiliation country: China Country of publication: Reino Unido